Preparing cancer patients for difficult decisions is an oncologist's job. They don't always remember to do it, however.
A new study demonstrates that a first-of-its-kind platform using artificial intelligence (AI) could help clinicians and patients assess whether and how much an individual patient may benefit from a ...
Leading private capital deals today include Blackstone's $300 million investment in DDN and a B Capital-led $275 million ...
Hippocratic AI, a startup building AI solutions that can handle non-diagnostic patient-facing tasks, secured a massive $141 ...
Nearly 30% of the funding poured into healthcare startups last year, including for biotechs, went to companies leveraging ...
AI can compare thousands of images to uncover dangerous patterns, create ultra-high resolution scans from low-res images and ...
The stake comes alongside an agreement for Vancouver, Washington-based Absci to use AMD chips and software to power its drug ...
Novo Nordisk on Wednesday announced an expanded deal with healthtech firm Valo Health to use AI to fuel drug discovery.
Novo Nordisk has expanded its partnership with Valo Health to advance new therapies for type 2 diabetes, obesity and ...
Novo Nordisk and Valo Health have expanded their 16-month-old collaboration into an up-to-$4.6 billion-plus artificial ...